Prelude Therapeutics (PRLD) Return on Capital Employed Growth (1y) (2021 - 2026)
Prelude Therapeutics (PRLD) Return on Capital Employed Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
31,429.00 |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
16,829.00 |
| 10 |
Prelude Therapeutics |
314.40 Mn |
169.80 Mn |
- |
620.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
620.00 |
| Dec 31, 2025 |
-7,384.00 |
| Sep 30, 2025 |
-6,372.00 |
| Jun 30, 2025 |
-5,897.00 |
| Mar 31, 2025 |
-4,481.00 |
| Dec 31, 2024 |
-3,321.00 |
| Sep 30, 2024 |
-2,522.00 |
| Jun 30, 2024 |
-1,112.00 |
| Mar 31, 2024 |
831.00 |
| Dec 31, 2023 |
519.00 |
| Sep 30, 2023 |
298.00 |
| Jun 30, 2023 |
-722.00 |
| Mar 31, 2023 |
-2,040.00 |
| Dec 31, 2022 |
-2,087.00 |
| Sep 30, 2022 |
-2,252.00 |
| Jun 30, 2022 |
-2,330.00 |
| Mar 31, 2022 |
-1,912.00 |
| Dec 31, 2021 |
-1,137.00 |
